LTS Lohmann Therapie-Systeme AG
Lohmannstr. 2
Andernach
D-56626
Germany
Tel: 49-2632 99-0
Fax: 49-2632-99-2200
Website: http://www.ltslohmann.de/
Email: ltsgroup@ltslohmann.de
9 articles about LTS Lohmann Therapie-Systeme AG
-
First product based on LTS Sorrel™ wearable drug delivery platform launched in the US
2/28/2024
LTS LOHMANN Therapie-Systeme AG announced that its customer Coherus BioSciences, Inc has launched its UDENYCA® on-body injector utilizing the LTS Sorrel™ wearable drug delivery platform.) UDENYCA® is a biosimilar pegfilgrastim administered the day after chemotherapy to decrease the incidence of infection as manifested by febrile neutropenia.
-
LTS receives grant of $1.2 Million to support the development of thermostable mRNA formulations for Microneedle Array Patches
12/6/2023
LTS, a leading pharmaceutical technology company, announced that it has received a grant from the Bill & Melinda Gates Foundation.
-
LTS takes next step in its Growth Journey with the acquisition of Tapemark Inc.
8/22/2022
LTS LOHMANN Therapie-Systeme AG announces the closing of the acquisition of Tapemark Inc. located in St. Paul, MN, USA.
-
Revive Therapeutics Enters into Feasibility Agreement with LTS Lohmann to Develop Oral Psilocybin Thin Film Strip
5/17/2021
Revive Therapeutics Ltd. (“Revive” or the “Company”) (CSE: RVV, USA: RVVTF, FRANKFURT: 31R), a specialty life sciences company focused on the research and development of therapeutics for medical needs and rare disorders, is pleased to announce it has entered into a feasibility agreement with LTS Lohmann Therapie-Systeme AG (“LTS”), a leader in pharmaceutical oral thin films, to develop and manufacture a proprietary oral psilocybin thin film strip
-
Intec Pharma Reports First Quarter 2018 Financial Results and Corporate Update
5/15/2018
Intec Pharma Ltd. (NASDAQ: NTEC) (TASE: NTEC) ("Intec" or "the Company") today announces financial results for the three months ended March 31, 2018 and provides a corporate update.
-
Novartis AG, BWK Sell Stakes In Patch Maker LTS Lohmann Therapie-Systeme AG, Pockets $400 Million From Sale
7/17/2014
-
Private Equity Firm Nordic Capital Leads Bids To Buy LTS Lohmann Therapie-Systeme AG
4/18/2014
-
Two Buyout Firms Vie For Patch Maker LTS Lohmann Therapie-Systeme AG -Sources
11/25/2013
-
IntelGenx Corp. Enters Strategic Manufacturing Partnership with LTS Lohmann Therapie-Systeme AG for VersaFilm Technology
1/25/2010